RA Capital Management closed the venture capital firm’s second venture fund at $461 million, aimed at a continued investment strategy into privately held life sciences companies.

U.S. health agencies, the European drug regulator and 16 top drugmakers will collaborate on vaccine and drug development efforts to fight the coronavirus pandemic, the U.S. National Institutes of Health said.

Biomedical engineers at the University of Minnesota conducted a first-of-its-kind study on molecular interactions.

Orchestra BioMed Inc., in partnership with Terumo Corporation, announced Breakthrough Device Designation was granted by the U.S. Food and Drug Administration for the biomedical innovation company’s Virtue Sirolimus-Eluting Balloon in the treatment of below-the-knee peripheral artery disease.

Researchers are having a hard time getting their hands on specimens for their work on new treatments, diagnostics, and cures.

The Vilcek Foundation announced the winners of the 2018 Vilcek Prizes in Biomedical Science. Awarded annually, the prizes call attention to the breadth of immigrant contributions to science in the United States. In parallel, the Vilcek Foundation also awards prizes for immigrant accomplishments in the arts.

Male physicians in the U.S. – across almost every specialty – took in more money from the biomedical industry in 2015 than their female peers, a new study suggests.

Eli Lilly and Company and Purdue University announced a strategic collaboration to conduct life science research. The five-year agreement, where Lilly will provide up to $52 million, marks Purdue’s largest strategic collaboration with a single company.

  Company to Begin Trading on Nasdaq on August 26, 2016: Shares Will Trade as BMRA   IRVINE, CA–(Marketwired – August 24, 2016) – Biomerica Inc. (OTCQB: BMRA) today announced that its common stock has been approved for listing on the Nasdaq Capital Market and is expected to commence trading on Nasdaq under the ticker […]